Bill Text: PA HR683 | 2011-2012 | Regular Session | Introduced


Bill Title: Designating the month of June 2012 as "Cockayne Syndrome Awareness Month" in Pennsylvania and commending the work of the Share and Care Cockayne Syndrome Network for raising awareness of this disease.

Sponsorship: Slight Partisan Bill (Republican 36-17)

Status: (Passed) 2012-06-11 - Adopted (196-0) [HR683 Detail]

Download: Pennsylvania-2011-HR683-Introduced.html

  

 

    

PRINTER'S NO.  3391

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

HOUSE RESOLUTION

 

No.

683

Session of

2012

  

  

INTRODUCED BY TOOHIL, BAKER, BRADFORD, BRENNAN, CALTAGIRONE, CLYMER, D. COSTA, CREIGHTON, DiGIROLAMO, DONATUCCI, EVERETT, FLECK, FRANKEL, GEIST, GEORGE, GILLEN, GILLESPIE, GINGRICH, GOODMAN, GRELL, GROVE, HACKETT, HARHART, HEFFLEY, HELM, HENNESSEY, HESS, HICKERNELL, KILLION, KIRKLAND, KNOWLES, KULA, MAHONEY, MAJOR, MANN, MARSICO, MILLARD, MOUL, MURT, MUSTIO, MYERS, O'NEILL, READSHAW, ROCK, ROSS, SANTARSIERO, SCAVELLO, SCHRODER, SONNEY, SWANGER, VULAKOVICH AND YOUNGBLOOD, APRIL 18, 2012

  

  

INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35, APRIL 18, 2012  

  

  

  

A RESOLUTION

  

1

Designating the month of June 2012 as "Cockayne Syndrome

2

Awareness Month" in Pennsylvania and commending the work of

3

the Share and Care Cockayne Syndrome Network for raising

4

awareness of this disease.

5

WHEREAS, Cockayne Syndrome, or CS, is a rare genetic disorder

6

affecting a small number of children worldwide, but its impact

7

on involved families is significant emotionally and

8

economically; and

9

WHEREAS, Edward Alfred Cockayne (1880-1956), after whom this

10

disease is named, was a London physician who concentrated

11

particularly on hereditary diseases of children; and

12

WHEREAS, CS is inherited in an autosomal recessive pattern;

13

therefore, in order for a child to be affected by CS, he or she

14

must inherit a mutation in the same CS gene from both parents;

15

and

- 1 -

 


1

WHEREAS, While parents, who are carriers of a single CS gene

2

mutation, remain healthy after the birth of a child with CS,

3

they have a one in four, or 25%, chance of having a second or

4

successive child with CS; and

5

WHEREAS, The symptoms of CS vary significantly, especially

6

with regard to the age of onset and rate of progression, and

7

include social, jovial personalities; sunburning easily;

8

progeria (premature aging); shortened life span; microcephaly;

9

neurodevelopment delay; short stature (height lower than the 5th

10

percentile for others in the age group); contractures; unsteady

11

gait; spasticity; rounded back; deep-set eyes and a small,

12

slender, straight nose; dental caries (cavities); retinopathy

13

and cataracts; hearing loss; poor circulation (cold hands and

14

feet); low body temperature; feeding problems; sleeping with

15

eyes open; tremors; white matter abnormalities; basal ganglia

16

calcifications; liver abnormalities; elevated liver enzymes;

17

hypertension; and severe itchiness; and

18

WHEREAS, The resulting spectrum of severity can be loosely

19

divided into three "types" of CS:

20

(1)  CS Type I is characterized by normal prenatal growth

21

with the onset of growth and developmental abnormalities

22

around one year of age. The typical lifespan is 10 to 20

23

years of age.

24

(2)  CS Type II is characterized by growth failure and

25

other abnormalities at birth, with little or no postnatal

26

neurological development. The typical lifespan is up to seven

27

years of age.

28

(3)  CS Type III is characterized by a later onset,

29

lesser symptoms and a slower rate of progression. The

30

expected lifespan is unclear, but can extend to 40 or 50

- 2 -

 


1

years of age;

2

and

3

WHEREAS, Some individuals have combined features of CS and

4

Xeroderma Pigmentosum, which is characterized by a wide range of

5

skin changes from mild freckling to skin cancer on areas exposed

6

to sunlight; and

7

WHEREAS, No specific treatment currently exists for CS, and

8

patients are treated according to the symptoms they have, with

9

physical, occupational, speech, vision and hearing therapies

10

being beneficial; and

11

WHEREAS, It is important to those affected by CS to raise

12

awareness of this disease so that they find social and medical

13

support easily, and the Share and Care Cockayne Syndrome Network

14

provides information and support for those afflicted; therefore

15

be it

16

RESOLVED, That the House of Representatives designate the

17

month of June 2012 as "Cockayne Syndrome Awareness Month" in

18

Pennsylvania and commend the work of the Share and Care Cockayne

19

Syndrome Network for raising awareness of this disease.

- 3 -

 


feedback